Eli Lilly vs. Novo Nordisk: One Has 39% Upside. I'm Picking the Other.
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
CNBC's The China Connection newsletter: China's weak consumer becomes the world's problem
A Group of 20 finance meeting in the U.S. this month has now elevated the debate over whether China's exports have cost people in other countries their jobs.
CapitaLand Targets $500 Million for Third Asian Credit Fund
Singapore’s CapitaLand Investment Ltd. is targeting $500 million in commitments from investors for its third Asia Pacific credit program, according to people familiar with the matter.
CNBC's The China Connection newsletter: China's weak consumer becomes the world's problem
A Group of 20 finance meeting in the U.S. this month has now elevated the debate over whether China's exports have cost people in other countries their jobs.
S. Korea's economy grows 0.6 pct in Q2, matching initial estimate: BOK
SEOUL, Sept. 8 (Yonhap) -- The South Korean economy grew 0.6 percent in the seco...
Metaplanet CEO breaks silence but shareholders say the hard questions remain unanswered
Simon Gerovich said Metaplanet had not adequately explained the structure, and denied involvement in MMXX Ventures’ trading decisions.
Citi Survey sees Banxico frozen as Peso holds below 18.00
Citi Mexico released its September “Expectations Survey,” in which most private economists expect the Bank of Mexico (Banxico) to hold rates unchanged, while the exchange rate is forecast to end below…